Press releases
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
- Sarepta Therapeutics to Present at Upcoming Investor Conferences
More ▼
Key statistics
On Friday, Sarepta Therapeutics Inc (AB3A:BER) closed at 113.45, -12.73% below its 52-week high of 130.00, set on Feb 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 113.45 |
---|---|
High | 113.45 |
Low | 113.45 |
Bid | 119.35 |
Offer | 119.90 |
Previous close | 112.70 |
Average volume | 64.20 |
---|---|
Shares outstanding | 94.52m |
Free float | 89.83m |
P/E (TTM) | 1,629.97 |
Market cap | 12.27bn USD |
EPS (TTM) | 0.0797 USD |
Data delayed at least 15 minutes, as of May 31 2024 07:08 BST.
More ▼